FOSTER DYKEMA CABOT & PARTNERS, LLC

Position in MRK — Merck & Co., Inc.

CIK 2011882 WALTHAM, MA

Position in MRK

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,108,441

+$70,820 QoQ

Shares Held

8,626

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#2,032

of 3,769 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FOSTER DYKEMA CABOT & PARTNERS, LLC holds $37,893,315 across 11 Drug Manufacturers - General names. MRK ranks #3 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	28,025	$33,614,028
2	JNJ	Johnson & Johnson	5,153	$1,308,707
3	MRK	Merck & Co., Inc. This page	8,626	$1,108,441
4	ABBV	AbbVie Inc.	3,815	$960,006
5	NVO	Novo Nordisk A S	4,526	$216,976
6	NVS	Novartis AG	1,094	$171,451
7	AZN	Astrazeneca PLC	820	$155,488
8	AMGN	Amgen Inc	420	$152,090

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,108,441	8,626	0.0%	Shares	Sole	2026-08-11
2026-03-31	$1,037,621	8,626	-2.6%	Shares	Sole	2026-05-14
2025-12-31	$932,603	8,860	-13.1%	Shares	Sole	2026-02-12
2025-09-30	$855,834	10,197	+8.3%	Shares	Sole	2025-11-12
2025-06-30	$745,528	9,418	0.0%	Shares	Sole	2025-08-12
2025-03-31	$845,359	9,418	-20.9%	Shares	Sole	2025-05-09
2024-12-31	$1,183,712	11,899	-2.7%	Shares	Sole	2025-02-13
2024-09-30	$1,388,838	12,230	+28.1%	Shares	Sole	2024-11-12
2024-06-30	$1,182,166	9,549	-1.0%	Shares	Sole	2024-08-14
2024-03-31	$1,273,185	9,649	+9.7%	Shares	Sole	2024-05-10
2023-12-31	$959,266	8,799	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.